相关实验视频
Updated: Jan 13, 2026

03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.1K
在sarcopenic肥胖症的背景下,微RNA的潜力
N Chobolová1, Z Švagera, D Stejskal
1Department of Clinical Biochemistry, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic. marek.buzga@osu.cz.
Physiological research
|January 9, 2026
概括
肥胖症 (sarcopenic obesity) 是一种多余脂肪和肌肉损失的疾病,会给健康带来风险. 微RNAs (miRNAs) 显示为早期检测的生物标志物和管理这种复杂疾病的潜在治疗点.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 身体生理学 身体生理学
背景情况:
- 肥胖症 (SO) 结合了多余的脂肪组织与肌肉质量和力量的损失,增加了代谢,心血管和功能衰退的风险.
- 微RNAs (miRNAs) 正在成为参与炎症,新陈代谢和肌肉健康的基因表达的关键调节者.
研究的目的:
- 审查关于在sarcopenic肥胖症中miRNA表达的当前知识.
- 在SO病理生理学中探索miRNAs的调节作用.
- 评估miRNAs作为诊断生物标志物和SO治疗剂的潜力.
主要方法:
- 对研究的文献综述研究研究miRNA表达在sarcopenic肥胖症.
- 对SO相关的细胞通路中的miRNA调节功能的分析.
- 评估miRNAs在SO诊断和治疗中的当前和潜在应用.
主要成果:
- 在患有sarcopenic肥胖症的患者中,特定miRNAs的调节失调.
- 这些miRNAs影响关键路径,包括炎症,新陈代谢和肌肉.
- 有证据表明miRNAs可以作为早期检测生物标志物和SO的治疗点.
结论:
- 微RNAs在 sarcopenic 肥胖症的发展和进展中发挥着重要作用.
- 在早期诊断和针对SO的向治疗方面,MiRNAs具有相当大的潜力.
- 需要进一步的研究,以充分阐明miRNA机制和SO管理中的临床实用性.
相关概念视频
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K

